An Intervention Program to Control Diabetes
Study to evaluate the effectiveness of a structured intervention to improve diabetes control.
Status: Completed (Phase 4). Started on May 1st, 2005.
Enrollment: 150 subjects
Study Type: Interventional
Study Design:
- Treatment
- Randomized
- Open Label
- Active Control
- Parallel Assignment
- Efficacy Study
Conditions:
Interventions:
- Other: daily enteral nutritional product and/or behavioral changes
Eligibility
Inclusion Criteria:
informed consent
18-70 adults
Type 2 Diabetes
Males and non-pregnant females
Exclusion Criteria:
Use of exogenous insulin for glucose control
Use of medications or supplements for weight loss
Advanced diabetes complications
Recent history of cardiovascular event
- Gender
Both
- Mininum Age
18 Years
- Maximum Age
70 Years
Resources
Source: Abbott Nutrition
Authority: China: Ethics Committee
Locations
-
Huandong Hospital
Shanghai
China
Officials
Jianqin Sun, MD, MPH (Principal Investigator, Clinical Nutrition Center, Huadong Hospital)
Sponsors
Abbott Nutrition (Lead Sponsor)
References
None.
Links
None.
- Date Verified
- October 1st, 2007
- First Received
- October 12th, 2007
- Last Changed
- October 12th, 2007
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.